Enhanced Lubricant Formulations with Antimicrobial Properties
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to novel lubricant compositions that combine the benefits of silicone polymers and antimicrobial agents, providing enhanced lubricity, comfort, and safety for users.
Background and Problem Solved
The original patent disclosed lubricant compositions with antimicrobial agents, but had limitations in terms of pH stability, skin hydration, and overall comfort. The present inventive concept addresses these limitations by introducing pH buffering agents, moisturizing agents, and optimized silicone polymer-antimicrobial agent ratios.
Detailed Description of the Inventive Concept
The inventive concept comprises lubricant compositions featuring a hybrid of silicone polymers (50-80% w/w) and antimicrobial agents (10-30% w/w), with the addition of pH buffering agents to maintain a pH range of 4.5-6.5. The silicone polymers may be a mixture of dimethicone and cyclomethicone, while the antimicrobial agents may include hypochlorite, acids, or salts thereof. The compositions may further include moisturizing agents such as glycerin, panthenol, or hyaluronic acid to enhance skin hydration and comfort. These compositions can be used in various applications, including personal lubricants, medical devices, and industrial machinery.
Novelty and Inventive Step
The new claims introduce the concept of pH buffering agents and moisturizing agents, which are not present in the original patent. The optimized ratios of silicone polymers and antimicrobial agents, as well as the specific combinations of these components, provide a non-obvious improvement over the prior art.
Alternative Embodiments and Variations
Alternative embodiments may include varying the type and amount of silicone polymers, antimicrobial agents, and pH buffering agents. Additional variations may involve incorporating other comfort-enhancing agents, such as aloe vera or vitamin E, or using different manufacturing processes to create the lubricant compositions.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the personal care, medical device, and industrial machinery industries. The enhanced lubricant formulations can provide improved user comfort, safety, and convenience, making them attractive to manufacturers and consumers alike.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0034 |
| A | A61 | A61K8/0216 |
| A | A61 | A61K8/20 |
| A | A61 | A61K8/24 |
| A | A61 | A61K8/25 |
| A | A61 | A61K8/891 |
| A | A61 | A61K33/20 |
| A | A61 | A61K47/02 |
| A | A61 | A61K47/34 |
| A | A61 | A61L31/14 |
| A | A61 | A61L31/16 |
| A | A61 | A61Q17/005 |
| A | A61 | A61Q19/00 |
| A | A61 | A61L2300/404 |
| A | A61 | A61L2400/10 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Personal care and medical lubricant formulations, with expertise in antimicrobial compositions, polymer chemistry, and emulsion technologies. Requires advanced degree in chemistry, materials science, or related field with specialized knowledge in formulation design and surface interactions
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with knowledge of silicone polymers, antimicrobial agents, and lubricant composition techniques. Capable of understanding chemical interactions, formulation optimization, and applying known techniques across related technological domains
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's lubricant composition. The addition of pH buffering and moisturizing agents are standard optimization techniques in personal care formulations. The specific combinations of silicone polymers, antimicrobial agents, and comfort-enhancing components represent routine design choices within the established technological framework of the source patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,674 |
|---|---|
| Title | Lubricant formulations |
| Assignee(s) | REOXCYN, LLC |